Immediate Impact
7 by Nobel laureates 55 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Ruixin Li being referenced
Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruixin Li | 244 | 84 | 268 | 239 | 129 | 1.2k | |
| Takashi Saito | 255 | 106 | 235 | 83 | 68 | 1.0k | |
| Kenichi Iwasaki | 174 | 103 | 325 | 65 | 89 | 1.1k | |
| Xiaofeng Shan | 357 | 66 | 198 | 104 | 110 | 1.1k | |
| Yabing Wang | 158 | 186 | 200 | 60 | 96 | 1.2k | |
| T Matsumura | 202 | 33 | 441 | 53 | 109 | 1.2k | |
| Kwang Ho Cho | 261 | 94 | 304 | 133 | 129 | 1.5k | |
| Kenji Hara | 647 | 15 | 438 | 60 | 61 | 1.7k | |
| Jun Lee | 263 | 58 | 364 | 68 | 71 | 1.6k | |
| Chunbo Li | 290 | 44 | 354 | 96 | 63 | 1.3k | |
| Kenji Satô | 287 | 62 | 288 | 144 | 98 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...